Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00341107
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2006-06-19
Brief Title:
Physicians Survey on Genetic Testing
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Physicians Survey on Genetic Testing
Status:
COMPLETED
Status Verified Date:
2006-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Research and development in genetic testing for cancer susceptibility genes has advanced rapidly in recent years allowing healthy individuals cancer patients and their families to determine if they carry mutations which increase their risk of breast ovarian prostate colon and other cancers Initial efforts have unfolded primarily in academic medical centers targeting families at high risk for cancer There is currently no information available for assessing the prevalence of genetic testing for cancer susceptibility genes at the national level or for evaluating the knowledge of and attitudes toward such testing among primary care physicians The objectives of this survey are to determine the utilization of genetic tests by physicians at the national level to ascertain physician knowledge of available genetic tests for specific cancer susceptibility genes to examine physicians general attitudes toward testing and to explore possible variation in utilization and knowledgeattitudes by medical specialty type of practice year of training completion board status urbanicity and geographic region The primary research question that this survey will address is what is the prevalence of use of genetic testing for cancer susceptibility among primary care physicians in the US The survey will also assess whether there are statistically significant differences in 1 self-reported knowledge current use of and future intentions to use genetic testing for cancer susceptibility and 2 perceptions of barriers to testing among primary care physicians by their type and location of practice and recency of training Primary care physicians internists obstetriciangynecologist family and general practitioners will also be compared with specialty groups gastroenterologists surgeons urologists and oncologists with respect to their use attitudes towards and knowledge of genetic testing for cancer susceptibility A questionnaire is being administered by mail telephone facsimilie or Internet to a nationally representative sample of 2100 physicians Responding physicians select their preferred response mode Study participants are primary care and specialty physicians with active licenses to practice medicine in the US A data file with personal identifiers deleted will be prepared for statistical analysis to estimate the prevalence and determine predictors of use and intentions to genetic tests for inherited cancer susceptibility
Detailed Description:
Research and development in genetic testing for cancer susceptibility genes has advanced rapidly in recent years allowing healthy individuals cancer patients and their families to determine if they carry mutations which increase their risk of breast ovarian prostate colon and other cancers Initial efforts have unfolded primarily in academic medical centers targeting families at high risk for cancer There is currently no information available for assessing the prevalence of genetic testing for cancer susceptibility genes at the national level or for evaluating the knowledge of and attitudes toward such testing among primary care physicians The objectives of this survey are to determine the utilization of genetic tests by physicians at the national level to ascertain physician knowledge of available genetic tests for specific cancer susceptibility genes to examine physicians general attitudes toward testing and to explore possible variation in utilization and knowledgeattitudes by medical specialty type of practice year of training completion board status urbanicity and geographic region The primary research question that this survey will address is what is the prevalence of use of genetic testing for cancer susceptibility among primary care physicians in the US The survey will also assess whether there are statistically significant differences in 1 self-reported knowledge current use of and future intentions to use genetic testing for cancer susceptibility and 2 perceptions of barriers to testing among primary care physicians by their type and location of practice and recency of training Primary care physicians general internists obstetriciangynecologist family and general practitioners will also be compared with specialty groups gastroenterologists surgeons urologists and oncologists with respect to their use attitudes towards and knowledge of genetic testing for cancer susceptibility A questionnaire was administered by mail telephone facsimilie or Internet to a nationally representative sample of 1251 primary care physicians and specialists Study participants are primary care and specialty physicians with active licenses to practice medicine in the US A data file with personal identifiers deleted will be prepared for statistical analysis to estimate the prevalence and determine predictors of use and intentions to genetic tests for inherited cancer susceptibility
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| OH99-C-N010 | None | None | None |